☆ 4.2 Editorial Material

'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine

PHARMACOGENOMICS (2012)

Get Full Text
Add to Collection

Journal

PHARMACOGENOMICS
Volume 13, Issue 10, Pages 1097-1100

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/PGS.12.75

Keywords

cardiovascular; generic drug products; genotyping; neuropsychiatric; personalized medicine; pharmacogenomics

Categories

Pharmacology & Pharmacy

Funding

  1. NCRR NIH HHS [G12RR-03051, G12 RR003051] Funding Source: Medline
  2. NHLBI NIH HHS [SC2 HL110393, HL110393] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.